Director, Therapeutic Area Strategy (CH / USA)

Your Responsibilities:
Bringing life-changing medicines to millions of people, Novartis sits at the intersection of cutting-edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs & an in-house marketplace for rotations & project work. With strong medicines pipeline our current transformation will not just deliver growth for our business but continue to allow us to bring innovative medicines to patients quickly

The Director, Therapeutic Area (TA) Strategy, will support a TA (Cardiovascular, Immunology, Haematology, Neuroscience, Solid Tumors or TAx) focused team. She/he will support the creation and update of a holistic Disease Area (DA) strategy comprising of internal and external licensing / acquisitions opportunities for a designated TA and supports integrated enterprise alignment across Novartis Institutes for Biomedical Research (NIBR), Global Drug Development (GDD) and Innovative Medicines (IM).

In this role, he/she will leverage external benchmarking, analysis, insights, and judgement to support the TA Strategy Head in developing a holistic Novartis strategy that achieves sustainable growth in short, mid and long-term. The ideal candidate will bring understanding of the pharmaceutical industry, the core TA and its DAs to derive insightful and differentiating competitive advantages over our peers. In addition, she/he will support development and delivery of strategic external insights across the core TA to inform identification of growth opportunities and emerging competitive challenges to growth, and support creation of a third-party view around key strategic levers, including commissioning targeted primary research.

This role can either be based in Basel, Switzerland and//or Boston, USA. Distant working agree-ments may be offered in these locations based on local employment and/or company guidelines. As a result, please note that international relocation or sponsoring from the US to Switzerland or vice versa will not be offered.

Within the US, the ideal location for this role is Boston, MA but remote work may be possible (there may be some restrictions based on legal entity). Please note that this role would not provide reloca-tion as a result. If associate is remote, all home office expenses and any travel/lodging to specific Boston, MA for periodic live meetings will be at the employee’s expense. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require some travel.

Your responsibilities include, but are not limited to:

Drive Portfolio Strategy and decision making:
• Support definition and delivery of mid-and-long term portfolio strategy, goals, strategic objectives and leadership aspiration within TA and DAs in collaboration with other functions within S&G and in IM, GSPC, GDD, & NIBR. Help drive stakeholder alignment around updates to the strategy as needed, e.g., due to internal or external market events
• Identify potential pipeline gaps and make recommendations to address with other S&G functions, IM, GDD and NIBR partners
• Collaborate closely with key stakeholders (e.g., GPSC, IM, NIBR, GDD, local functions such as Market Access & Pricing) to facilitate portfolio decision making in the context of our goal of becoming a top 5 Pharma player in the US while maintaining our international leadership
• Support assessments of programs fit to current portfolio strategy, and drive content development to facilitate portfolio prioritization / de-prioritization / trade-off discussions for Innovation Management Board (IMB)
• Support DA strategic insights development and forecasting, including Forecasting Consortium challenge sessions for programs prior to IMB review

Optimize the early-stage TA portfolio
• Support forecasting, commercial viability, unmet needs (esp. US), evidence strategy and LCM considerations to inform NIBR product strategy, including identification of key data requirements to support transition of assets to DDP / FDP (Development Decision Point / Full Development Decision Point)
• For assets post DDP/ FDP that have transitioned to the GPT, work in collaboration with GPSC lead to optimize sequencing of additional lifecycle indications and develop proposals for IMB review

Provide external perspective and identify growth opportunities:
• Provide commercial input into BD&L, triage opportunities, review non-confidential information and decision making for evaluations and conduct market research together with Insights and Analytics for opportunity sizing and business case preparation. Drive strategic insights and outside-in challenge of internal assumptions around core pipeline and external opportunities (e.g., forecast assumptions) and within key portfolio governance processes. Support white space exploration with Novartis Strategy and diligence and external landscape mapping with BD&L and M&A
•Support commercial discussions on partnering opportunities for internal and external portfolio with top Pharma companies, support commercial DD activities and synthesis of commercial recommendations. Support Licensing and Merger and Acquisition commercial evaluations
• Assist Group Investor Relations and the CEO Office with dissemination of key strategic insights

Others:
• Provide support to the broader TA Strategy Group in helping challenge and develop other TA Strategy Directors